Kelsen JR, Conrad MA, Dawany N, Patel T, Shraim R, Merz A, Maurer K, Sullivan KE and Devoto M. The Unique Disease Course of Children with Very Early Onset-Inflammatory Bowel Disease. Inflammatory Bowel Diseases. Published online September 27, 2019. DOI: 10.1093/ibd/izz214.
Patel TT, Conrad MA, Kelsen JR. Common Threads in Pediatric Inflammatory Diseases: Insight into Personalized Medicine. JAMA Pediatrics. Published online June 18, 2018. doi:10.1001/jamapediatrics.2018.1169
Sun B, Banugaria SG, Prater SN, Patel TT, Fredrickson K, Ringler DJ, de Fougerolles A, Rosenberg AS, Waldmann H, Kishnani PS. Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease. Molecular Genetics and Metabolism Reports. 1(2014):446-450.
Banugaria SG, Prater SN, Patel TT, Dearmey SM, Milleson C, Sheets KB, Bali DS, Rehder CW, Raiman JA, Wang RA, Labarthe F, Charrow J, Harmatz P, Chakraborty P, Rosenbergy AS, Kishnani PS. Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic maternal-negative classic infantile pompe disease: a step towards improving the efficacy of ERT. PLoS One. 8(2013): e67052.
Prater SN*, Patel TT*, Buckley AF, Mandel H, Vladovski E, Banugaria SG, Feeney EJ, Raben N, Kishnani PS. Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy. Orphanet Journal of Rare Diseases. 8(2013): 90.
Patel TT, Banugaria SG, Frush DP, Enterline DS, Tanpaiboon P, Kishnani PS. Basilar artery aneurysm: a new finding in classic infantile Pompe disease. Muscle and Nerve. 47(2012):613-615.
Banugaria SG, Patel TT, Kishnani PS. Immune modulation in Pompe disease treated with enzyme replacement therapy. Expert Review of Clinical Immunology. 6(2012):497-499.
Patel TT, Banugaria SG, Case LE, Wenninger S, Schoser B, Kishnani PS. The impact of antibodies in late-onset Pompe disease: a case series and literature review. Molecular Genetics and Metabolism. 106 (2012): 301-309.
Banugaria SG, Patel TT, Mackey J, Das S, Amalfitano A, Rosenberg A, Charrow J, Chen YT, Kishnani PS. Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: Need for agents to target antibody-secreting plasma cells. Molecular Genetics and Metabolism. 105(2012): 677-680.
Patel T, Kelsen JR. Gastrointestinal Differential Diagnosis of Food Protein-Induced Enterocolitis Syndrome. In: Food-Protein Induced Enterocolitis Syndrome – Diagnosis and Management, Brown-Whitehorn T, Cianferoni A, editors, Springer, 2019.
Posters and Presentations
Patel T, Conrad MA, Shraim R, Merz A, Maurer K, Dawany N, Devoto M, Behrens E, Bunin NJ, Freedman JL, Giraudo C, Sullivan KE, Kelsen JR. Integration of Clinical, Immunologic and Genomic Data in Children with Very-Early Onset Inflammatory Bowel Disease Leads to Identification of Candidates for Curative Therapy with Stem Cell Transplantation. Oral presentation. Digestive Disease Week. San Diego, CA. May 2019.
Patel T, Conrad MA, Shraim R, Merz A, Maurer K, Dawany N, Devoto M, Behrens E, Bunin NJ, Freedman JL, Giraudo C, Sullivan KE, Kelsen JR. Identifying a Signature of Immune-Mediated Monogenic Defects Amenable to Hematopoietic Stem Cell Transplantation in Very Early Onset Inflammatory Bowel Disease. Oral presentation. Komarov Research Prize Competition. Philadelphia, PA. June 2019.
Patel T, Conrad MA, Moser E, Field NS, Maurer K, Dawany N, Giraudo CC, Henrickson S, Wherry EJ, Devoto M, Bunin NJ, Freedman JL, Heimall J, Arnold DE, Markowitz J, Oliver P, Sullivan KE, Kelsen JR. Novel Treatment of Itch Deficiency in Very Early-Onset Inflammatory Bowel Disease with Hematopoietic Stem Cell Transplantation. Poster Presentation. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting. Chicago, IL. October 2019.
Kelsen J, Conrad M, Dawany N, Merz A, Shraim R, Patel T, Sullivan K, Devoto M, Hamilton K. Understanding Phenotypic Distinctions in Sub-Populations of Very Early-Onset Inflammatory Bowel Disease. Poster Presentation. Digestive Disease Week. Washington, DC. June 2018.
Patel T, Shraim R, Maurer K, Dawany N, Conrad M, Sullivan, K, Kelsen J. Immunophenotyping of Very Early Onset Inflammatory Bowel Disease Patient: Monocyte Subpopulation Analysis. Presented as Poster Presentation. Digestive Disease Week. Washington, DC. June 2018.
Patel T, Conrad M, McDermott J, Dawany N, Devoto M, Sullivan K, Kelsen J. Infantile-Onset Inflammatory Bowel Disease and Lymphoma as a Presentation of IL-10R Deficiency. Abstract Presented as Poster Presentation. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting. Las Vegas, NV. November 2017.
Awards and Honors
2018, GI Fellow Citizenship Award, Children's Hospital of Philadelphia
2012, Southeastern Regional Genetics Group Trainee Travel Award
Editorial and Academic Positions
Academic and Institutional Committees
2018-present, Quality Improvement Group, Center for Inflammatory Bowel Disease
Leadership and Memberships
Memberships in Professional Organizations
2016-present, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
- 2018-present, Fellows Committee
2018-present, Crohn’s & Colitis Foundation
2016-present, American Gastroenterological Association
2013-present, American Academy of Pediatrics
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.